Continuous Glucose Monitoring in Adults with Type 1 Diabetes: Real-World Data from the German/Austrian Prospective Diabetes Follow-Up Registry.

Diabetes Technology & Therapeutics
Dirk SandigReinhard W Holl

Abstract

Background: To analyze key indicators of metabolic control in adults with type 1 diabetes (T1D) using real-time or intermittent scanning continuous glucose monitoring (rtCGM/iscCGM) during real-life care, based on the German/Austrian/Swiss Prospective Diabetes Follow-up (DPV) registry. Methods: Cross-sectional analysis including 233 adults with T1D using CGM. We assessed CGM metrics by gender, age group (18 to <30 years vs. ≥30 years), insulin delivery method (multiple daily injections vs. continuous subcutaneous insulin infusion [CSII]) and sensor type (iscCGM vs. rtCGM), working days versus weekends, and daytime versus night-time using multivariable linear regression models (adjusted for demographic variables) or Wilcoxon signed-rank test. Results: Overall, 79/21% of T1D patients used iscCGM/rtCGM. Those aged ≥30 years spent more time in range (TIR [70-180 mg/dL] 54% vs. 49%) and hypoglycemic range <70 mg/dL (7% vs. 5%), less time in hyperglycemic range >180 mg/dL (38% vs. 46%) and had a lower glucose variability (coefficient of variation [CV] 36% vs. 37%) compared with adults aged <30 years. We found no significant differences between genders. Multivariable regression models revealed the highest Time In Range (TIR) and lowes...Continue Reading

References

Oct 26, 2005·Diabetes Technology & Therapeutics·Irl B Hirsch
Oct 27, 2006·Diabetes Care·Boris P KovatchevWilliam Clarke
Oct 14, 2009·Diabetes Technology & Therapeutics·Christian Weber, Oliver Schnell
Feb 13, 2010·Diabetes Care·James W AlbersUNKNOWN Diabetes Control and Complications Trial /Epidemiology of Diabetes Interventions and Complications Research Group
Oct 6, 2010·Diabetes Care·Lois JovanovicDavid J Pettitt
Oct 16, 2013·Journal of Diabetes Science and Technology·Susana R Patton, Mark A Clements
Nov 19, 2013·Diabetic Medicine : a Journal of the British Diabetic Association·V ZoffmannM Due-Christensen
May 31, 2014·Journal of Diabetes Science and Technology·Greg MaynardKendall Rogers
May 31, 2014·Journal of Diabetes Science and Technology·Maureen MonaghanRandi Streisand
Feb 17, 2015·World Journal of Diabetes·Klaus-Dieter KohnertEckhard Salzsieder
Dec 14, 2016·The New England Journal of Medicine·Rachel E ShermanRobert M Califf
Dec 21, 2016·Diabetes Technology & Therapeutics·Ahmed H El-LaboudiNick S Oliver
Feb 24, 2017·Journal of Managed Care & Specialty Pharmacy·Wenhui WeiMark S Matusik
Jul 28, 2017·Journal of Diabetes Science and Technology·Andreas ThomasRobert A Vigersky
Dec 24, 2018·Diabetes Technology & Therapeutics·Robert A Vigersky, Chantal McMahon
Jan 15, 2019·Journal of Diabetes Science and Technology·Roy W BeckDavid Rodbard
Jun 19, 2019·The Journal of Clinical Endocrinology and Metabolism·Saeed Reza Toghi-Eshghi, Jane E Yardley
Jun 21, 2019·Diabetes Technology & Therapeutics·Ana María GómezFabian Mauricio León Vargas
Aug 14, 2019·The American Journal of the Medical Sciences·Zainab MianAlicia Jenkins
Sep 27, 2019·Diabetic Medicine : a Journal of the British Diabetic Association·J M HermannUNKNOWN T1D Exchange Clinic Network and the DPV initiative
Dec 22, 2019·Diabetes Care·UNKNOWN American Diabetes Association

❮ Previous
Next ❯

Citations

Oct 28, 2020·Diabetes Technology & Therapeutics·David Rodbard
Jun 2, 2021·Diabetes Technology & Therapeutics·Laurel H Messer, Stuart A Weinzimer
Jul 17, 2021·Diabetes Technology & Therapeutics·Bruce BodeDebra Ignaut
Jul 7, 2021·Diabetes & Metabolism Journal·Antonia KietaiblLatife Bozkurt

❮ Previous
Next ❯

Software Mentioned

SAS

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.